Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 57, 320-325, January 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blagosklonny, M. V.
Right arrow Articles by El-Deiry, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blagosklonny, M. V.
Right arrow Articles by El-Deiry, W. S.

Defects in p21WAF1/CIP1, Rb, and c-myc Signaling in Phorbol Ester-resistant Cancer Cells

Mikhail V. Blagosklonny, Nita S. Prabhu and Wafik S. El-Deiry1

Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania Comprehensive Cancer Center, Howard Hughes Medical Institute, Department of Medicine and Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

Growth arrest and differentiation of leukemic cells by phorbol 12-myristate 13-acetate (PMA) is accompanied by p53-independent activation of p21WAF1/CIP1 and c-myc down-regulation. We show that despite p21 induction in 7 of 12 human cancer cell lines treated with PMA, growth inhibition was observed only in two cell lines (SKBr3 breast and LNCaP prostate cancer cells). Treatment of SKBr3 and LNCaP cells with PMA was followed by Raf-1 hyperphosphorylation, p21 induction, Rb hypophosphorylation, c-myc down-regulation and growth inhibition. The 10 remaining PMA-resistant cell lines were comprised of 5 that failed to induce p21 and 5 that induced p21 but had defects in steps putatively downstream of this (Rb hypophosphorylation and c-myc down-regulation). Exogenous expression and subsequent failure to down-regulate c-myc protein expression in SKBr3 and LNCaP cells was correlated with acquisition of resistance to the growth inhibitory effect of PMA. Exogenous p21 expression down-regulated c-myc protein in PMA-sensitive cancer cells. Our findings suggest that induction of p21 and down-regulation of c-myc may be necessary steps in a PMA-induced growth-inhibitory pathway in cancer cells.

1 Assistant Investigator of the Howard Hughes Medical Institute and to whom requests for reprints should be addressed, at Howard Hughes Medical Institute Research Labs, University of Pennsylvania School of Medicine, Clinic Research Building, Room 437A, 415 Curie Blvd., Philadelphia, PA 19104-6148. Fax: (215) 573-9139.

Received 3/ 7/96. Accepted 11/12/96.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
M. S. Ricci, Z. Jin, M. Dews, D. Yu, A. Thomas-Tikhonenko, D. T. Dicker, and W. S. El-Deiry
Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity
Mol. Cell. Biol., October 1, 2004; 24(19): 8541 - 8555.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Zhang and P. K. H. Chow
The Effect of Megestrol Acetate on Growth of HepG2 Cells In vitro and In vivo
Clin. Cancer Res., August 1, 2004; 10(15): 5226 - 5232.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. C. Day, M. T. McCabe, X. Zhao, Y. Wang, J. N. Davis, J. Phillips, M. Von Geldern, T. Ried, M. A. KuKuruga, G. R. Cunha, et al.
Rescue of Embryonic Epithelium Reveals That the Homozygous Deletion of the Retinoblastoma Gene Confers Growth Factor Independence and Immortality but Does Not Influence Epithelial Differentiation or Tissue Morphogenesis
J. Biol. Chem., November 8, 2002; 277(46): 44475 - 44484.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Venkateswaran, L. H. Klotz, and N. E. Fleshner
Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Human Prostate Carcinoma Cell Lines
Cancer Res., May 1, 2002; 62(9): 2540 - 2545.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Okegawa, R.-C. Pong, Y. Li, J. M. Bergelson, A. I. Sagalowsky, and J.-T. Hsieh
The Mechanism of the Growth-inhibitory Effect of Coxsackie and Adenovirus Receptor (CAR) on Human Bladder Cancer: A Functional Analysis of CAR Protein Structure
Cancer Res., September 1, 2001; 61(17): 6592 - 6600.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. V. Blagosklonny and A. B. Pardee
Exploiting Cancer Cell Cycling for Selective Protection of Normal Cells
Cancer Res., June 1, 2001; 61(11): 4301 - 4305.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sumitomo, R. Shen, J. S. Goldberg, J. Dai, D. Navarro, and D. M. Nanus
Neutral Endopeptidase Promotes Phorbol Ester-induced Apoptosis in Prostate Cancer Cells by Inhibiting Neuropeptide-induced Protein Kinase C {{delta}} Degradation
Cancer Res., December 1, 2000; 60(23): 6590 - 6596.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
K. Salnikow, M. Costa, W. D. Figg, and M. V. Blagosklonny
Hyperinducibility of Hypoxia-responsive Genes without p53/p21-dependent Checkpoint in Aggressive Prostate Cancer
Cancer Res., October 1, 2000; 60(20): 5630 - 5634.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
C. Shelly, L. Petruzzelli, and R. Herrera
K562 Cells Resistant to Phorbol 12-Myristate 13-acetate-induced Growth Arrest: Dissociation of Mitogen-activated Protein Kinase Activation and Egr-1 Expression from Megakaryocyte Differentiation
Cell Growth Differ., September 1, 2000; 11(9): 501 - 506.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. Okegawa, Y. Li, R.-C. Pong, J. M. Bergelson, J. Zhou, and J.-T. Hsieh
The Dual Impact of Coxsackie and Adenovirus Receptor Expression on Human Prostate Cancer Gene Therapy
Cancer Res., September 1, 2000; 60(18): 5031 - 5036.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
K. Detjen, F. Brembeck, M Welzel, A Kaiser, H Haller, B Wiedenmann, and S Rosewicz
Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest
J. Cell Sci., January 9, 2000; 113(17): 3025 - 3035.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Park, S. Boyer, K. Mitchell, D. Gilfor, M. Birrer, G. Darlington, W. El Deiry, G. L. Firestone, K. Munger, V. Band, et al.
Expression of Human Papilloma Virus E7 Protein Causes Apoptosis and Inhibits DNA Synthesis in Primary Hepatocytes via Increased Expression of p21Cip-1/WAF1/MDA6
J. Biol. Chem., January 7, 2000; 275(1): 18 - 28.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
K. O. Mitchell and W. S. El-Deiry
Overexpression of c-Myc Inhibits p21WAF1/CIP1 Expression and Induces S-Phase Entry in 12-O-Tetradecanoylphorbol-13-acetate (TPA)-sensitive Human Cancer Cells
Cell Growth Differ., April 1, 1999; 10(4): 223 - 230.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
X. Zhao, J. E. Gschwend, C. T. Powell, R. G. Foster, K. C. Day, and M. L. Day
Retinoblastoma Protein-dependent Growth Signal Conflict and Caspase Activity Are Required for Protein Kinase C-signaled Apoptosis of Prostate Epithelial Cells
J. Biol. Chem., September 5, 1997; 272(36): 22751 - 22757.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1997 by the American Association for Cancer Research.